Held virtually on June 23rd, our 2022 Mass General Cancer Center Survivorship Conference featured speakers Ryan Sullivan, MD, who reviewed the role of targeted therapies and immunotherapies in melanoma survivorship and how these treatments can impact patients, and Giselle Perez, PhD, who discussed the importance of attending to the post-treatment psychosocial needs of patients with cancer. The event was moderated by Jeffery Peppercorn, MD, MPH, Survivorship and Supportive Care Director.

1 of 1

  • Jeffrey Peppercorn, MD, MPH

    • Hematology/Oncology
    • Department of Medicine

  • Giselle Perez-Lougee, PhD

    • Associate Director, Adolescent and Young Adult Cancer Program
    • Director, Adolescent and Young Adult Research and the Mind Body Program for Cancer Survivors
    • Assistant Professor of Psychology, Harvard Medical School

  • Ryan Sullivan, MD

    • Director, Center for Melanoma

Related Programs

Type

Centers and Departments

Topics